Analyst Ratings for ISIS Pharmaceuticals (isis)

isis Rating Summary

isis Price Target Summary

* Over Last 12-Mos
  |   Expand Research on isis
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $51.71 (+28.7%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/26/2014 Leerink Swann New Coverage Market Perform
(N/A)
40.00
(N/A)
40.30 40.18 -0.3% Details
8/12/2014 Laidlaw New Coverage Buy
(N/A)
52.00
(N/A)
34.79 40.18 15.49% Details
Like ISIS Ratings? Also take a look at SAN, SNY, GSK, BIIB

ISIS Ratings News